Correlation Between Visa and NovaBay Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Visa and NovaBay Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and NovaBay Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and NovaBay Pharmaceuticals, you can compare the effects of market volatilities on Visa and NovaBay Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of NovaBay Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and NovaBay Pharmaceuticals.
Diversification Opportunities for Visa and NovaBay Pharmaceuticals
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Visa and NovaBay is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and NovaBay Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NovaBay Pharmaceuticals and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with NovaBay Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NovaBay Pharmaceuticals has no effect on the direction of Visa i.e., Visa and NovaBay Pharmaceuticals go up and down completely randomly.
Pair Corralation between Visa and NovaBay Pharmaceuticals
Taking into account the 90-day investment horizon Visa is expected to generate 1.54 times less return on investment than NovaBay Pharmaceuticals. But when comparing it to its historical volatility, Visa Class A is 5.16 times less risky than NovaBay Pharmaceuticals. It trades about 0.33 of its potential returns per unit of risk. NovaBay Pharmaceuticals is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest 55.00 in NovaBay Pharmaceuticals on August 29, 2024 and sell it today you would earn a total of 6.00 from holding NovaBay Pharmaceuticals or generate 10.91% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. NovaBay Pharmaceuticals
Performance |
| Timeline |
| Visa Class A |
| NovaBay Pharmaceuticals |
Visa and NovaBay Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and NovaBay Pharmaceuticals
The main advantage of trading using opposite Visa and NovaBay Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, NovaBay Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NovaBay Pharmaceuticals will offset losses from the drop in NovaBay Pharmaceuticals' long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| NovaBay Pharmaceuticals vs. Immix Biopharma | NovaBay Pharmaceuticals vs. Cns Pharmaceuticals | NovaBay Pharmaceuticals vs. Sonnet Biotherapeutics Holdings | NovaBay Pharmaceuticals vs. ZyVersa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |